Subscribe
25 July 2024NewsAmericasLiz Hockley

Panitch Schwarze brings in molecular biologist

Scientist and patent attorney joins boutique IP firm in Philadelphia | Former in-house counsel brings expertise representing variety of life sciences clients.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
IP firm lands attorney with ‘deep experience’ in research and innovation
28 November 2023   With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team.
Careers
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
4 July 2024   New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.
Big Pharma
Foley Hoag strengthens biotech team with Fenwick & West patent expert
13 June 2024   New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

article
IP firm lands attorney with ‘deep experience’ in research and innovation
28 November 2023   With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team.
Careers
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
4 July 2024   New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.
Big Pharma
Foley Hoag strengthens biotech team with Fenwick & West patent expert
13 June 2024   New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies.

More on this story

article
IP firm lands attorney with ‘deep experience’ in research and innovation
28 November 2023   With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team.
Careers
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
4 July 2024   New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.
Big Pharma
Foley Hoag strengthens biotech team with Fenwick & West patent expert
13 June 2024   New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies.

More features

UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Bristol Myers Squibb leader named INTA 2025 president
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks